Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a 'Cultural Bridge' in therapy reduce dropout rates?

NCT ID NCT06625502

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new training program called CARE, designed to help therapists build a stronger bond with patients who come from a different cultural background. Forty Asian American participants will receive up to 15 online therapy sessions from therapists trained in this approach. The goal is to see if this improves patient engagement, satisfaction, and mental health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Culturally-Affirming Racial Equity (CARE) framework (behavioural intervention)
What this could lead to
If successful, this could point toward a practical way to improve mental health care for diverse populations by strengthening the therapist-patient bond.
What could go wrong
This is a small, early feasibility study with only 40 participants, so results may not apply broadly. The intervention is behavioural and may not work for all cultural mismatches.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patient Participants: 1. Individuals 18 years of age or older 2. Physically residing in New York or New Jersey and willing to meet therapist over video platform 3. English-language proficient 4. Seeking telemental health treatment and willing to receive short-term treatment (maximum 15 sessions) 5. Willingness to have sessions videorecorded and complete online assessments 6. Has insurance coverage for therapy sessions or willing to pay for services out-of-pocket ($150/session) Therapist Participants: 1. Masters' or doctoral level mental health provider licensed to practice in NY or NJ and insured 2. 2+ years of clinical experience post-licensure 3. Training and experience with cognitive behavioral therapy or other evidence-based therapies 4. Interest in improving skills in working across therapist-patient differences 5. Willingness to complete post-session questionnaires, record treatment sessions and attend biweekly AFT sessions for training and research purposes 6. Availability to treat a caseload of 5 Unmute patients during the project period Exclusion Criteria: Patient Participants: 1. Patient's symptom presentation is severe beyond what can be effectively managed in a short-term treatment modality via telehealth (e.g., PHQ-9 score greater than 20, they present a risk of harm to self or other, or otherwise require a higher level of care) 2. Patient is involved in another intervention study or currently receiving psychotherapy services from another provider.suicidal ideation or psychotic symptoms 3. Therapist Participants: Licensure violations or enforcement actions as documented at the New York State Office of the Professions https://www.op.nysed.gov/ or New Jersey Division of Consumer Affairs https://www.njconsumeraffairs.gov

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Unmute Enterprise Inc. [A telehealth company]

    Chelsea, Massachusetts, 02150, United States

  • Virtual/Telehealth

    New York, New York, 10001, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.